BVF PARTNERS L P/IL

CIK 1055947
Transactions on file
39
Open-market buys
3
Win rate (buys)
100%
3 scored
Avg % since filing (buys)
+151.3%

Tickers traded

Recent activity

FiledTxn dateIssuerRolesCodeSharesValue% since FilingFiling
2026-07-162026-07-14XOMA
XOMA Royalty Corp
10%
U772,000$0.00open →
2026-07-162026-07-14XOMA
XOMA Royalty Corp
10%
U412,000$0.00open →
2026-07-162026-07-14XOMA
XOMA Royalty Corp
10%
U2,773,545$0.00open →
2026-07-162026-07-14XOMA
XOMA Royalty Corp
10%
U3,635,758$0.00open →
2026-06-262026-06-26KYMR
Kymera Therapeutics, Inc.
DirectorOther
Sale51,858$5.52M+3.8%open →
2026-06-262026-06-26KYMR
Kymera Therapeutics, Inc.
DirectorOther
Sale113,289$12.07M+3.8%open →
2026-06-262026-06-26KYMR
Kymera Therapeutics, Inc.
DirectorOther
Sale627,597$66.84M+3.8%open →
2026-06-262026-06-26KYMR
Kymera Therapeutics, Inc.
DirectorOther
Sale837,914$89.24M+3.8%open →
2026-05-182026-05-14XOMA
XOMA Royalty Corp
10%
C772,000$3.11M+896.8%open →
2026-05-182026-05-14XOMA
XOMA Royalty Corp
10%
C412,000$1.66M+896.8%open →
2026-05-182026-05-14XOMA
XOMA Royalty Corp
10%
C1,506,000$6.07M+896.8%open →
2026-05-182026-05-14XOMA
XOMA Royalty Corp
10%
C2,313,000$9.32M+896.8%open →
2025-01-142025-01-10OLMA
Olema Pharmaceuticals, Inc.
DirectorOther
Disp.22,740open →
2025-01-142025-01-10OLMA
Olema Pharmaceuticals, Inc.
DirectorOther
Disp.235,450open →
2025-01-142025-01-10OLMA
Olema Pharmaceuticals, Inc.
DirectorOther
Disp.161,810open →
2025-01-282025-01-24XOMA
XOMA Royalty Corp
10%
Sale339,679$8.87M+53.9%open →
2025-01-282025-01-24XOMA
XOMA Royalty Corp
10%
Sale149,975$3.91M+53.9%open →
2025-01-282025-01-24XOMA
XOMA Royalty Corp
10%
Sale85,776$2.24M+53.9%open →
2025-01-282025-01-24XOMA
XOMA Royalty Corp
10%
Sale75,287$1.96M+53.9%open →
2025-05-192025-05-15ALLK
Allakos Inc.
10%
Disp.6,777,935open →
2025-05-192025-05-15ALLK
Allakos Inc.
10%
Disp.8,679,726open →
2025-05-192025-05-15ALLK
Allakos Inc.
10%
Disp.855,211open →
2025-05-202025-05-16XOMA
XOMA Royalty Corp
10%
Sale265,316$7.19M+48.2%open →
2025-05-202025-05-16XOMA
XOMA Royalty Corp
10%
Sale127,407$3.45M+48.2%open →
2025-06-172025-06-13CBIO
GLYCOMIMETICS INC
10%
Other657,308open →
2025-06-172025-06-13CBIO
GLYCOMIMETICS INC
10%
Other556,617open →
2025-06-172025-06-13CBIO
GLYCOMIMETICS INC
10%
Other56,079open →
2025-10-142025-10-09EPIX
ESSA Pharma Inc.
10%
U560,797$0.00open →
2025-10-142025-10-09EPIX
ESSA Pharma Inc.
10%
U4,726,743$0.00open →
2025-10-142025-10-09EPIX
ESSA Pharma Inc.
10%
U6,194,145$0.00open →
2025-07-012025-06-30KYMR
Kymera Therapeutics, Inc.
DirectorOther
Buy142,604$6.27M+151.3%open →
2025-07-012025-06-30KYMR
Kymera Therapeutics, Inc.
DirectorOther
Buy115,783$5.09M+151.3%open →
2025-07-012025-06-30KYMR
Kymera Therapeutics, Inc.
DirectorOther
Buy58,780$2.59M+151.3%open →
2025-08-072025-08-05EPIX
ESSA Pharma Inc.
10%
X203,336$0.00open →
2025-08-072025-08-05EPIX
ESSA Pharma Inc.
10%
X1,235,030$0.00open →
2025-08-072025-08-05EPIX
ESSA Pharma Inc.
10%
X1,481,634$0.00open →
2025-08-072025-08-05EPIX
ESSA Pharma Inc.
10%
Sale66$124.08open →
2025-08-072025-08-05EPIX
ESSA Pharma Inc.
10%
Sale11$20.68open →
2025-08-072025-08-05EPIX
ESSA Pharma Inc.
10%
Sale79$148.52open →